baber/WOPTO huggingface dataset:
Patent JP-H0524888-B2 (JP)
IPC: A61K9/22
Filed: 1986-10-13
Abstract: The present invention relates to obtaining isosorbide-5-mononitrate tablets, being also of retard form, which are stable in time. Such embodiment is now possible after the discovery of the stabilizing activity of the polyvinylpyrrolidone with respect to the isosorbide-5-mononitrate with which it forms a solid solution. The use of PVP is essential so that the tablets can remain stable in time: the retard effect in turn can be obtained with the use of hydroxyalkylcelluloses.
Patent JP-H0544381-B2 (JP)
Inventor: KURISUTEIAN GYUNTERU
IPC: B61D27/00
Filed: 1984-12-01
Abstract: 1. Arrangement for the ventilating and air-conditioning of passenger compartments (1) in rail vehicles with the aid of an air-conditioning installation (3), which has a fresh-air inlet (2) into the passenger compartment and at least one air outlet (4) from the passenger compartment, characterised in that a regulator (12) is provided for regulating the internal pressure (Pi ) of the passenger compartment, in that arranged in the fresh-air inlet (2) and in at least one air outlet (4) are respectively sensors (8, 9) which emit output signals (Vin , Vout ) as a function of the rates of air flow (Win Wout ) flowing through the fresh-air inlet (2) or respectively through the air outlet (4) in that a desired-value transmitter (13) is provided to which the output signal (Vout ) of the sensor (9) in the air outlet (4) is supplied and which supplies a desired value (Vin , desired), dependent upon this output signal, for the rate of air flow flowing through the fresh-air inlet (2), in that the output of the desired-value transmitter (13) and that of the sensor (9) in the fresh-air inlet (2) are connected to a difference member (14) for the formation of an adjusting signal (Fdiaphragm ) and in that provided with the output of this difference member (14) as adjusting member (6, 7) in the air inlet (2) is a diaphragm (6) which varies the flow cross-section thereof.
Patent JP-H0775884-B2 (JP)
IPC: B41F21/08
Filed: 1992-09-24
Abstract: A chain operated sheet transport and transfer mechanism for sheet-fed printing machines having a plurality of printing units. The chain operated mechanism includes a plurality of gripper cars affixed to chains for movement between the printing units. The gripper cars each have a gripper impact strip and a pivotable gripper finger, with the gripper strip of each car extending the width of the gripper car and being of concave configuration. A bending device at the transfer zone of each printing unit is operable for acting on the gripper car to bend the concave gripper impact strips straight in order that sheets are transferred from one printing unit to the other without register deviation.
Patent JP-2539167-B2 (JP)
IPC: H04L12/56
Filed: 1993-10-20
Granted: 1996-10-02
Abstract: Disclosed are a method and a system for transmitting a message or data packet from a single sender (21) to a plurality, i.e. a group of receivers, usually called multicasting, within a conventional unicast transmission network, i.e. a network basically not equipped to handle such multicast transmissions, consisting of a plurality of subnetworks (22 - 24) The nodes or gateways (25 - 29) connecting the subnetworks maintain tables of multicast receiving stations (or groups of such) and the header of each message includes information defining the groups of the addressed multicast receiving stations. <IMAGE>
Patent JP-3092676-B2 (JP)
IPC: H01L25/065
Filed: 1991-10-17
Granted: 2000-09-25
Abstract: PURPOSE:To obtain a compact printed board together with a package and obtain a compact system as a whole, by replacing a part of printed board for mounting with a package when assembling a semiconductor chip three- dimensionally. CONSTITUTION:A first semiconductor chip is installed and wire bonding is performed. Then, a die pad plate 22 with a heat sink is mounted by inserting pins 25 into pin holes 8' and 8. After a second semiconductor chip is installed on the die pad plate 22 and wire bonding is performed, potting is performed with a potting resin. A fin 22' for heat dissipation of the die pad plate 22 has a shape protruding out of a package. Thus, heat dissipation of the present semiconductor device can be improved about three times that of the conventional semiconductor device by mounting the die pad plate 22 having a gland conductor or the fin 22' acting to dissipate heat. Further, a lighter weight can be obtained due to no molding, resulting in about one-third the conventional device in weight.
Patent JP-2961189-B2 (JP)
IPC: A61K38/00
Filed: 1990-10-17
Granted: 1999-10-12
Abstract: The invention relates to the use of a polypeptide having human interleukin-2 activity for preparing a pharmaceutical composition intended for the treatment of leukaemias. Polypeptide having human IL-2 activity is understood to mean natural human IL-2 or recombinant human IL-2, that is to say obtained by recombinant DNA technology. The leukaemias to which the invention relates comprise chronic myeloid or chronic lymphoid leukaemias and acute lymphoid or non-lymphoblastic leukaemias, for example myeloid leukaemias characterised in a general manner by the proliferation of blast cells.
Patent JP-3720098-B2 (JP)
IPC: H01R25/00
Filed: 1995-10-31
Granted: 2005-11-24
Abstract: An automation of process control system has a large number of modules that can provide output functions for operating a wide range of actuators, e.g. motors, and input functions for such as sensors. The modules (2) are mounted on a bus system that allows interconnection between modules. The connection system is supported on a mounting rail (1) and has formed conductor tracks that couple with connector sockets (7). Each module has contact pins projecting from the underside and these engage sockets (11). Connection points (27) are formed along the edges and plug connectors allow coupling to a bus strip (13) that runs the length of the unit.
Patent JP-3163994-B2 (JP)
IPC: B60K6/442
Filed: 1996-10-07
Granted: 2001-05-08
Abstract: After an elapse of a predetermined time period or after a run of a predetermined distance, a power output system of the present invention heats a catalytic converter with a catalyst heater while enabling an engine to be driven under a driving condition suitable for checking a catalyst packed in the catalytic converter for deterioration of the catalytic function. The power output system then measures a variation in temperature of the catalyst in this state and determines whether or not the variation is within a normal range, thereby detecting the deteriorating catalytic function of the catalyst, that is, abnormality of the catalytic converter. This structure enables the power output system to realize accurate detection of abnormality of the catalytic converter at a sufficient frequency. During the measurement of the temperature change of the catalyst, an assist motor is driven and controlled to output a torque Td* corresponding to a step-on amount of an accelerator pedal to a drive shaft. This enables a desired power to be output to the drive shaft even during the course of the abnormality detection. Detection of abnormalities in an engine supercharger and exhaust gas recirculation system is also provided.
Patent JP-2920076-B2 (JP)
IPC: C23C4/06
Filed: 1994-11-07
Granted: 1999-07-19
Abstract: A coating composition comprising an alloy having the formula RCrAlR'R'' wherein R is nickel, cobalt or the like; R' is yttrium or hafnium and R'' is tantalum, rhenium and/or platinum, preferably mixed with an oxide dispersion such as alumina, to provide an improved class of coatings suitable for operating in high temperature oxidizing environments.
Patent JP-2935717-B2 (JP)
IPC: A61F13/49
Filed: 1989-12-20
Granted: 1999-08-16
Abstract: A garment (12) for holding a removable absorbent core (30) is disclosed. The garment (12) does not require separate fastening means to hold the core in position. The garment features two tapered flaps (14) which overlay the core to retain it in the desired position and obviate the necessity of separate fastening means. The flaps (14) are monotonically tapered to provide maximum overlap of the core at the rear waist margin (26) of the garment, for greater frictional engagement with the core, and less core overlap at the front waist margin (24) of the garment, to provide a larger urine target zone.
Patent JP-H0459916-B2 (JP)
IPC: A61M25/00
Filed: 1988-12-28
Abstract: An angiographic catheter (43) includes a relatively soft, tip portion (45) having a preformed curvature, and a resilient body portion (47) extending therefrom having a preformed curvature in the opposite direction. A lumen (49) extends through the catheter for the injection of angiographic dye therethrough to the right coronary artery. The part of the body portion (47) of the catheter which it in the aortic arch of the patient during use has an amount of curvature which is less than the amount of curvature of the aortic arch, so that the body portion of the catheter is resiliently deformed where it passes through the aortic arch. The deformation results in the biassing of the tip portion (45) of the catheter into the ostium of the right coronary artery. Upon insertion into the aorta the preformed catheter is oriented so that the curvature of the body portion of the catheter corresponds in direction to the curvature of the aortic arch, the tip portion of the catheter being disposed above the ostium of the right coronary artery with the distal end of the tip portion touching the wall of the ascending aorta. The tip portion of the catheter is moved down the wall of the ascending aorta until it reaches the ostium of the right coronary artery.
Patent JP-3209553-B2 (JP)
IPC: A61K31/70
Filed: 1991-12-26
Granted: 2001-09-17
Abstract: Disclosed herein is a combination of an antiviral nucleoside analog and a ribonucleotide reductase inhibiting peptide derivative. The combination is useful for treating herpes infections.
Patent JP-3549559-B2 (JP)
IPC: C07K16/00
Filed: 1993-12-24
Granted: 2004-08-04
Abstract: The invention relates to a process for reactivating purified membrane proteins.
Patent JP-2556196-B2 (JP)
IPC: H04L27/227
Filed: 1989-12-14
Granted: 1996-11-20
Abstract: There is provided a method of and apparatus for Automatic Frequency Control (AFC) in the presence of data. It comprises removing the effects of data modulated onto the carrier (25), detecting the frequency difference between the carrier frequency and the phase of the reference oscillator (30), and adjusting (80) the frequency of the reference oscillator (35) to eliminate the frequency difference ( DELTA ). It is further characterized by digitizing (40) the modulated carrier in quadrature, sampling (20) the modulated carrier in quadrature at a multiple of the modulated bit rate, rotating phases toward arctangent (I/Q)=0 (25/55/60) to remove the effects of quadrature data (I/Q) modulated onto the carrier, detecting (30) the frequency difference ( DELTA ) between the carrier frequency and the frequency of a Voltage Controlled type of reference oscillator (35) with a phase trajectory estimator (45), and establishing and generating the requisite correction voltage ( DELTA ) for a Voltage Controlled type of reference oscillator (VCO) (35) with the phase trajectory estimator (45). <IMAGE>
Patent JP-3558647-B2 (JP)
IPC: C08F4/02
Filed: 1996-06-05
Granted: 2004-08-25
Abstract: An applicator tip for dispensing a polymerizable and/or cross-linkable material which is porous, absorbent or adsorbent and includes a polymerization or cross-linking initiator. The initiator initiates polymerization or cross-linking when the polymerizable and/or cross-linkable material is dispensed through the applicator tip. The polymerizable and/or cross-linkable material may be applied to a variety of substrates.
Patent JP-2721038-B2 (JP)
IPC: H04B10/43
Filed: 1990-02-26
Granted: 1998-03-04
Abstract: Apparatus for generating of a comb having a large number optical teeth and comprises an optical loop (3) including an optical amplifier (5) a frequency shifter (4) and an optical filter (6). A signal from a laser (9) is partially coupled into the loop by a coupler (7) such that a part of it is output at output port (10). The signal in the loop (the feedback signal) is amplified by the amplifier (5) and frequency shifted by the frequency shifter (4) and is then partially coupled out of the loop by coupler (7). The part coupled out of the loop (the output signal) exits via output port 10. This process is repeated to produce the desired number of output signals exiting via output port 10. The signal from the laser (9) may be continuous or pulsed.
Patent JP-H0710716-B2 (JP)
IPC: B65D88/02
Filed: 1985-09-12
Abstract: This invention relates to a collapsible container comprising a bottom unit (1:1'), four angle posts (7:7'), two longitudinal side walls, two end walls (11:11') and an upper unit (12:12') supported by the end walls (11:11'). The reason for the container being made collapsible is to make it possible to place a number of folded-up containers in an unfolded container of the same kind at so-called return freight. What characterizes the container of the invention is that the side doors (8:8') forming the side alls are collapsible to packages, which are pivotable relative to the angle posts (7:7'). Moreover, the angle posts (7:7') with intermediate end wall (11:11') are pivotable relative to the bottom unit, the folded-up container having such dimensions that there is room for it in an unfolded container of the same type.
Patent JP-3801653-B2 (JP)
IPC: C07D209/14
Filed: 1998-06-18
Granted: 2006-07-26
Abstract: Hydrazine derivatives of the formulawherein Y is CO or SO2; R1 is lower alkyl, lower alkenyl, lower cycloalkyl, lower cycloalkyl-lower alkyl, aryl or aryl-lower alkyl; R2 is lower alkyl, halo-lower alkyl, aryl-lower alkyl, aryl-lower alkenyl or aryl when Y is SO2 and is lower alkyl, halo-lower alkyl, lower alkoxy, lower alkoxycarbonyl, acyl, lower cycloalkyl, aryl, aryl-lower alkyl, aryl-lower alkoxy or NR5R6 when Y is CO; and R3 is hydrogen, lower alkyl optionally substituted by cyano, amino, hydroxy, lower alkoxy, lower alkoxycarbonyl, heterocyclyl or heterocyclylcarbonyl, lower alkenyl, lower alkynyl, lower cycloalkyl, lower cycloalkyl-lower alkyl, aryl-lower alkyl, aryl-lower alkenyl, aryl or heterocyclyl; or R2 and R3 together form the residue of a 5-, 6- or 7-membered cyclic amide, cyclic imide, cyclic sulphonamide or cyclic urethane group; R4 is lower alkyl, hydroxy-lower alkyl, lower alkenyl, lower cycloalkyl, lower cycloalkyl-lower alkyl or a group of the formula X-aryl, X-heteroaryl or -(CH2)1-2-CH=CR7R8; X is a spacer group; R5 and R6 each individually are hydrogen, lower alkyl or aryl-lower alkyl; and R7 and R8 together represent a lower alkylene group in which one methylene group is optionally replaced by a hetero atom; and their pharmaceutically acceptable salts inhibit not only the release of tumour necrosis factor (TNF-alpha) and transforming growth factor (TGF-alpha) from cells, but also keratinocyte proliferation. They are useful as medicaments, especially for the treatment of inflammation, fever, hemorrhage, sepsis, rheumatoid arthritis, osteoarthritis, multiple sclerosis or psoriasis.
Patent JP-3577317-B2 (JP)
IPC: G01J3/28
Filed: 1995-08-31
Granted: 2004-10-13
Abstract: A calibration method and device for a fluorescence spectrometer which uses fluorescence from a homogeneous solid state standard as the source of calibration fluorescence and wherein the solid state standard may be built into the optical scanner and the calibration may be automatically performed as a routine step when using the optical scanner. A gold standard establishes fluorescent units, and the fluorescence spectrometer is calibrated by reference to calibration standards, such as calibration rubies, which are themselves rated against the gold standard and built into the fluorescence spectrometer to provide an unchanging reference to the gold standard and by which simultaneous calibration of two or more channels of a multi-channel fluorescence spectrometer may be accomplished, including automatically calibrating a multi-channel optical scanner when it is turned on to achieve an acceptable level of sensitivity in each channel and to adjust for any relative shift in sensitivity between the channels.
Patent JP-3782457-B2 (JP)
IPC: A23L29/10
Filed: 1996-09-13
Granted: 2006-06-07
Abstract: A new method for producing a fractionated vegetable oil from a plant material. The plant material is extracted with a non-polar solvent and the solvent is evaporated giving a crude oil which includes non-polar and polar lipids. The crude oil is mixed with an alcohol at a controlled temperature and a resulting alcoholic phase is separated and evaporated to recover a polar lipid rich fractionated vegetable oil. The invention also refers to the use of the polar lipid rich fractionated vegetable oil as a surface active agent.
Patent JP-3553591-B2 (JP)
IPC: A61P3/02
Filed: 1993-03-23
Granted: 2004-08-11
Abstract: PCT No. PCT/DK93/00105 Sec. 371 Date Apr. 4, 1994 Sec. 102(e) Date Apr. 4, 1994 PCT Filed Mar. 23, 1993 PCT Pub. No. WO93/19044 PCT Pub. Date Sep. 30, 1993.The invention relates to compounds of formula I in which formula X is hydrogen or hydroxy; R1 and R2 stand for hydrogen or a C1-C6 hydrocarbyl radical; or taken together with the carbon atom bearing the group X, can form a C3-C8 carbocyclic ring; R3 stands for hydrogen or a C1-C10 hydrocarbyl radical or for YR4, in which Y stands for the radicals -CO-, -CO-O-, -CO-S-, -CS-, -CS-O-, -CS-S-, -SO- or SO2-, and R4 stands for hydrogen or a C1-C10 hydrocarbyl radical; Q is a single bond or a C1-C8 hydrocarbylene diradical. R1,R2,R3 and/or Q may be optionally substituted with one or more deuterium or fluorine atoms. The compounds show an antiinflammatory and immunomodulating effect as well as stong activity in inducing differentiation and inhibiting undesirable proliferation of certain cells.
Patent JP-3188454-B2 (JP)
IPC: H01R13/18
Filed: 1991-10-24
Granted: 2001-07-16
Abstract: PCT No. PCT/EP91/02018 Sec. 371 Date Jun. 25, 1992 Sec. 102(e) Date Jun. 25, 1992 PCT Filed Oct. 24, 1991 PCT Pub. No. WO92/09120 PCT Pub. Date May 29, 1992.In a flat contact socket with two spring contact arms elastically touching at a distance from the free ends over part of their length, arranged on the socket body and bent back at the free ends, and with outer springs supported on the contact arms or the purposes of easy and secure insertion of the flat contact socket into the socket housing, the socket body is firmly surrounded by an outer spring body and the outer spring body is provided at the diameter wall sections with arm parts, extending over the flat sides of the contact arms and obliquely to the free ends and to one another. In addition, the free ends of the arm parts are bent back over part of their length over the free ends of the contact arms against one another and in the insertion direction and arranged to press against the free ends of the contact arms.
Patent JP-3789473-B2 (JP)
IPC: C08G69/26
Filed: 1995-11-16
Granted: 2006-06-21
Abstract: The invention provides a continuous process for the preparation of polyamides, equipment in which the polymerization process can be conducted, and process control methods for said polymerization process.
Patent JP-3084485-B2 (JP)
IPC: C08G63/82
Filed: 1994-12-16
Granted: 2000-09-04
Abstract: PCT No. PCT/GB94/02748 Sec. 371 Date Jun. 12, 1996 Sec. 102(e) Date Jun. 12, 1996 PCT Filed Dec. 16, 1994 PCT Pub. No. WO95/18170 PCT Pub. Date Jul. 6, 1995A process for the preparation of macromonomers by reaction between a lactone and a hydroxyalkylacrylate in the presence of >200 ppm phosphoric acid catalyst is provided. The reaction takes place in the presence of a free radical inhibitor at a temperature of from 100 DEG  to 130 DEG  C. Preferably, the lactone is  epsilon -caprolactone and the hydroxyalkylacrylate is selected from the group consisting of 2-hydroxyethylacrylate and 2-hydroxyethylmethacrylate.
Patent JP-4111403-B2 (JP)
IPC: A61K47/48
Filed: 1997-10-09
Granted: 2008-07-02
Abstract: Immunostimulatory polynucleotide-immunomodulatory molecule conjugate compositions are disclosed. These compositions include a polynucleotide that is linked to an immunomodulatory molecule, which molecule comprises an antigen and may further comprise immunomodulators such as cytokines and adjuvants. The polynucleotide potion of the conjugate includes at least one immunostimulatory oligonucleotide sequence (ISS). Methods of modulating an immune response upon administration of the polynucleotide-immunomodulatory conjugate preparation to a vertebrate host are also disclose.
Patent JP-3197905-B2 (JP)
IPC: C07C65/11
Filed: 1997-10-16
Granted: 2001-08-13
Abstract: The present invention relates to a process for preparing 2-hydroxynaphthalene-3,6-dicarboxylic acid which comprises reacting potassium 2-naphtholate and carbon dioxide at a temperature 290 DEG C or higher under a pressure 30kg/cm<2> (G) or higher. According to this process, 2-hydroxynaphthalene-3,6-dicarboxylic acid can be obtained in high yield.
Patent JP-3596891-B2 (JP)
IPC: A61K8/00
Filed: 1994-02-24
Granted: 2004-12-02
Abstract: Improved sunscreen compositions and their methods of manufacture are provided. The sunscreen compositions include extracts of cereal plants and an optional sunscreen blocking agent. The compositions optionally also may include dihydroxycinnamic derivatives.
Patent JP-4577913-B2 (JP)
IPC: A61K47/32
Filed: 1997-11-21
Granted: 2010-11-10
Abstract: A method for producing individually dosed active substance-containing and, in particular, aromatic-containing, film-shaped administration form, rapidly disintegrating upon contact with a liquid, wherein the aromatic is present as an internal, liposoluble phase in the form of liquid droplets distributed within an outer, solid but water-soluble phase, is characterized in that the said outer phase contains: at least 40% (w/w) polyvinyl alcohol 0 to 30% (w/w), of a surface-active substance, and that the constituent amount of the inner phase, relative to the outer phase, is between 0.1 and 30% (w/w), in each case relative to the water-free portions.
Patent JP-3701972-B2 (JP)
IPC: A61K8/00
Filed: 1995-05-11
Granted: 2005-10-05
Abstract: PCT No. PCT/FR95/00618 Sec. 371 Date Nov. 7, 1996 Sec. 102(e) Date Nov. 7, 1996 PCT Filed May 11, 1995 PCT Pub. No. WO95/31177 PCT Pub. Date Nov. 23, 1995A cosmetic or pharmaceutical, particularly dermatological, composition including an effective amount of laminarin or laminarin-derived oligosaccharides as the active ingredient. It has been discovered that laminarin, oligosaccharides derived therefrom and compositions containing same have stimulating, regenerating, conditioning and energising effects on human dermis fibroblasts and human epidermis keratinocytes. Said composition is useful in cosmetics and pharmacology.
Patent JP-3745376-B2 (JP)
IPC: A61B5/1455
Filed: 1996-06-04
Granted: 2006-02-15
Abstract: A blood glucose monitoring system includes a broadband light source and a specially fabricated optical filter for modulating optical radiation to be transmitted through a fleshy medium. Optical radiation which passes through the fleshy medium is detected by an optical detector which generates an electrical signal indicative of the intensity of the detected light. Digital signal processing is performed on the electrical signal to extract those optical characteristics of the electrical signal due to the optical characteristics of the filter and constituents of the fleshy May 1, 1995 medium other than blood glucose concentration. The monitoring system employs a unique "double-log" transformation to minimize errors due to indeterminate path length variations of the optical radiation through the fleshy medium. The monitoring system further employs specialized signal processing to avoid inaccuracies due to the previously unidentified solvent effect which arises when glucose is dissolved into water.